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Objectives
Candidial infection is associated with high mortality in
critically ill patients. Fungal infections compose a major
problem in intensive care units in both developed and
developing countries. Candidemia is associated with a
prolonged hospital stay, resulting in increasedcosts, and
high mortality.
Methods
This study was conducted in a 12-bed adult respiratory
intensive care unit (>18 years). Clinical and laboratory
data from patients with candidial infection were collected
retrospectively.
Results
Median age was 70.1 ± 14.60 years (min 18 years, max
91 years). The median APACHE II score on admission
was 21.28 ± 5.39. A total of 405 episodes were identified
from 2007 to 2014. The rates of candidial infections
were urinary tract infection (67.6%), blood stream infec-
tion (23.5%) and pneumonia (8.9%). The fungi identified
were yeast (54.32%), C. albicans (26.40%), C. tropicalis
(5.91%), C. glabrata (6.91%), C. parapsilosis (3.20%),
C. krusei (1.23%), Candida kefyr (0.98%) and other Candida
species (1.23%) (Table1). Candida albicans accounted for
57.29% of all Candida species. Fluconazole resistance was
found in 35.42%. The susceptibility to amphotericine B was
96.94%. Itraconazole resistance was 70.22%. None of all
patiens was using previously antifungal therapy. Primary
therapy included monotherapy with fluconazole (n = 99),
caspofungin (n = 14), anidulafungin (n = 8) and voricona-
zole (n = 8). Combination therapy was infrequently used
(n = 6). The mortality rate was 77.6% (n = 184). The use of
broad-spectrum antibiotics was 85.2%. The presence of an
intravascular device was 70% (n = 164). The use of parent-
eral (n = 66), enteral nutrition (n = 46) and both (n = 98)
were 27.8%, 19.4% and 41.4% respectively. The median
mechanic ventilation days were 13.3 ± 15.96 days. The
median RICU length of stay (LOS) was 24.8 ± 24.19 days.
The most patients (61.18%) came to RICU from other
departments and care units.
Conclusions
In conclusion, candidial infections associated with high
mortality, APACHE II score, LOS, ventilation days and
use of broad-spectrum antibiotics.
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Table 1. Candida Species in Culture Types
n(%) UTI (n:274) BSI (n:95) BAL (n:36) Total
Yeast 201 (73.36) 13 (13.68) 6 (16.67) 220 (54.32)
C.albicans 39 (14.23) 50 (52.63) 17 (47.22) 106 (26.17)
C. tropicalis 7 (2.55) 14 (14.74) 3 (8.33) 24 (5.93)
C. glabrata 13 (4.74) 8 (8.42) 7 (19.44) 28 (6.91)
C. parapsilosis 1 (0.36) 9 (9.47) 3 (8.33) 13 (3.21)
C. krusei 4 (1.46) 1 (1.05) 0 5 (1.23)
C. kefyr 4 (1.46) 0 0 4 (0.99)
Other C. species 5 (1.82) 0 0 5 (1.23)
Total 274 (67.6) 95 (23.5) 36 (8.9) 405
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